Urea hydantoin derivatives as formyl peptide modulators
Abstract:
The present invention relates to urea hydantoin compounds, processes for preparing them, pharmaceutical compositions containing them, and their use as pharmaceuticals as modulators of the FPR2 receptor, and to methods of treating inflammatory diseases or conditions in a subject in need thereof by administering the compound(s) or pharmaceutical composition to the subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0